Lam Research [LRCX] vs Teradyne [TER] Detailed Stock Comparison
Lam Research
NASDAQ
Loading...
Teradyne
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lam Research wins in 13 metrics, Teradyne wins in 7 metrics, with 0 ties. Lam Research appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lam Research | Teradyne | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.13 | 40.91 | Lam Research |
| Price-to-Book Ratio | 12.88 | 6.63 | Teradyne |
| Debt-to-Equity Ratio | 48.23 | 2.62 | Teradyne |
| PEG Ratio | 23.45 | -0.70 | Teradyne |
| EV/EBITDA | 19.90 | 27.63 | Lam Research |
| Profit Margin (TTM) | 29.07% | 16.59% | Lam Research |
| Operating Margin (TTM) | 33.67% | 14.87% | Lam Research |
| EBITDA Margin (TTM) | 33.67% | 14.87% | Lam Research |
| Return on Equity | 58.24% | 16.85% | Lam Research |
| Return on Assets (TTM) | 18.40% | 9.25% | Lam Research |
| Free Cash Flow (TTM) | $5.41B | $474.08M | Lam Research |
| Dividend Yield | 1.21% | 0.51% | Lam Research |
| 1-Year Return | 33.20% | -1.50% | Lam Research |
| Price-to-Sales Ratio (TTM) | 6.88 | 6.65 | Teradyne |
| Enterprise Value | $125.12B | $18.52B | Lam Research |
| EV/Revenue Ratio | 6.79 | 6.55 | Teradyne |
| Gross Profit Margin (TTM) | 50.08% | 57.23% | Teradyne |
| Revenue per Share (TTM) | $14 | $17 | Teradyne |
| Earnings per Share (Diluted) | $4.15 | $2.89 | Lam Research |
| Beta (Stock Volatility) | 1.66 | 1.72 | Lam Research |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lam Research vs Teradyne Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lam Research | 0.73% | -5.72% | -0.68% | 16.83% | 28.98% | 34.93% |
| Teradyne | -0.81% | 2.26% | 13.16% | 46.88% | 13.09% | -5.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lam Research | 33.20% | 116.81% | 232.45% | 1,261.28% | 2,600.00% | 3,042.77% |
| Teradyne | -1.50% | 34.66% | 59.68% | 568.70% | 1,153.98% | 617.21% |
Performance & Financial Health Analysis: Lam Research vs Teradyne
| Metric | LRCX | TER |
|---|---|---|
| Market Information | ||
| Market Cap | $97.28B | $19.19B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 10,541,380 | 3,228,860 |
| 90 Day Avg. Volume | 11,625,150 | 4,338,397 |
| Last Close | $97.74 | $119.63 |
| 52 Week Range | $56.32 - $108.02 | $65.77 - $144.16 |
| % from 52W High | -9.52% | -17.02% |
| All-Time High | $113.00 (Jul 08, 2024) | $168.91 (Dec 27, 2021) |
| % from All-Time High | -13.50% | -29.18% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | -0.11% |
| Quarterly Earnings Growth | 0.69% | -0.58% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.17% |
| Operating Margin (TTM) | 0.34% | 0.15% |
| Return on Equity (TTM) | 0.58% | 0.17% |
| Debt to Equity (MRQ) | 48.23 | 2.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.77 | $17.82 |
| Cash per Share (MRQ) | $5.05 | $2.31 |
| Operating Cash Flow (TTM) | $6.17B | $792.55M |
| Levered Free Cash Flow (TTM) | $4.42B | $428.48M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.21% | 0.51% |
| Last 12-Month Dividend | $1.18 | $0.60 |
Valuation & Enterprise Metrics Analysis: Lam Research vs Teradyne
| Metric | LRCX | TER |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.13 | 40.91 |
| Forward P/E | 23.45 | 27.82 |
| PEG Ratio | 23.45 | -0.70 |
| Price to Sales (TTM) | 6.88 | 6.65 |
| Price to Book (MRQ) | 12.88 | 6.63 |
| Market Capitalization | ||
| Market Capitalization | $97.28B | $19.19B |
| Enterprise Value | $125.12B | $18.52B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.79 | 6.55 |
| Enterprise to EBITDA | 19.90 | 27.63 |
| Risk & Other Metrics | ||
| Beta | 1.66 | 1.72 |
| Book Value per Share (MRQ) | $7.77 | $17.82 |
Financial Statements Comparison: Lam Research vs Teradyne
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LRCX | TER |
|---|---|---|
| Revenue/Sales | $5.17B | $685.68M |
| Cost of Goods Sold | $2.58B | $270.34M |
| Gross Profit | $2.59B | $415.34M |
| Research & Development | $580.18M | $118.19M |
| Operating Income (EBIT) | $1.74B | $135.32M |
| EBITDA | $1.93B | $164.64M |
| Pre-Tax Income | $1.78B | $119.02M |
| Income Tax | $58.89M | $14.54M |
| Net Income (Profit) | $1.72B | $98.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LRCX | TER |
|---|---|---|
| Cash & Equivalents | $6.39B | $475.63M |
| Total Current Assets | $14.52B | $1.76B |
| Total Current Liabilities | $6.57B | $649.07M |
| Long-Term Debt | $3.73B | $50.42M |
| Total Shareholders Equity | $9.86B | $2.80B |
| Retained Earnings | $28.99B | $893.23M |
| Property, Plant & Equipment | $23.22M | $604.61M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LRCX | TER |
|---|---|---|
| Operating Cash Flow | $1.78B | $134.09M |
| Capital Expenditures | N/A | $-64.02M |
| Free Cash Flow | $2.38B | $97.62M |
| Debt Repayment | $-1.49M | N/A |
| Common Stock Repurchase | $-1.29B | $-157.48M |
Short Interest & Institutional Ownership Analysis
| Metric | LRCX | TER |
|---|---|---|
| Shares Short | 34.14M | 7.34M |
| Short Ratio | 2.87 | 1.59 |
| Short % of Float | 0.03% | 0.05% |
| Average Daily Volume (10 Day) | 10,541,380 | 3,228,860 |
| Average Daily Volume (90 Day) | 11,625,150 | 4,338,397 |
| Shares Outstanding | 1.27B | 161.72M |
| Float Shares | 1.26B | 158.42M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.89% | 1.04% |
Dividend Analysis & Yield Comparison: Lam Research vs Teradyne
| Metric | LRCX | TER |
|---|---|---|
| Last 12-Month Dividend | $1.18 | $0.60 |
| Last 12-Month Dividend Yield | 1.21% | 0.51% |
| 3-Year Avg Annual Dividend | $0.89 | $0.50 |
| 3-Year Avg Dividend Yield | 0.29% | 0.11% |
| 3-Year Total Dividends | $2.66 | $1.50 |
| Ex-Dividend Date | Sep 24, 2025 | Sep 05, 2025 |